Section Navigation
Section Navigation
- Module 2 Overview
HIV PrEP In-Depth Topics - 0%Lesson 1
HIV PrEP for Adolescents and Young AdultsActivities- 0%Lesson 2
HIV PrEP for WomenActivities- 0%Lesson 3
HIV PrEP for People Who Inject DrugsQuick ReferenceHIV PrEP In-Depth Topics Overview
Target Audience
These topics explore content addressed in the HIV PrEP Fundamentals module in more detail. The selected topics focus on populations where less HIV PrEP data exists, as well as considerations for same-day HIV PrEP and how to provide HIV PrEP in sexual health clinic settings.Editor
David H. Spach, MDDavid H. Spach, MD
Editor-in-Chief
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures: None1Lesson 1 HIV PrEP for Adolescents and Young Adults
- Learning Objectives
- Describe the intersection of sexual debut, substance use, and sexual activities that can increase risk of HIV acquisition for adolescents and young adults
- Review HIV PrEP coverage among adolescents and young adults in the United States
- Summarize the HIV and sexually transmitted infections epidemiology, clinical trial evidence, and indications that support the use of HIV PrEP in adolescents and young adults
- Discuss the clinical management of HIV PrEP for adolescents and young adults, including obtaining a sexual history, choosing HIV PrEP medications, and laboratory monitoring
- Cite the legal and insurance issues of providing HIV PrEP services to adolescents and young adults
- Quick ReferenceHIV PrEP for Adolescents and Young Adults Core Concepts
- Background and HIV PrEP Coverage in Youth
- Epidemiology of STIs and HIV in Youth
- Evidence for HIV PrEP in Youth
- Clinic Visits and Obtaining a Sexual History in Adolescents
- Assessing for HIV PrEP in Youth
- HIV PrEP Medications for Youth
- Baseline Laboratory Evaluation
- Medication Adherence
- Follow-Up and Laboratory Monitoring
- Legal and Insurance Issues
- Summary Points
2Lesson 2 HIV PrEP for Women
- Learning Objectives
- Explain how intimate partner violence impacts the risk for HIV acquisition among women, including pregnant women
- Provide a rationale for prescribing HIV PrEP for women of childbearing age
- Summarize the HIV epidemiology, clinical trial evidence, and indications that support the use of HIV PrEP in women and in pregnant women
- Explore the risks and benefits of using HIV PrEP in pregnant women during the periconception period, pregnancy, or with breastfeeding
- Discuss the clinical management of HIV PrEP for women and pregnant women including sexual history, baseline evaluation, HIV PrEP medications, follow-up monitoring, and adherence
- Quick ReferenceHIV PrEP for Women Core Concepts
- Background
- Epidemiology of HIV in Women
- Evidence for HIV PrEP in Women
- Evidence for HIV PrEP in Pregnant Women and During Breastfeeding
- HIV PrEP Indications for Women
- Recommended HIV PrEP Medication Options for Women
- Interaction of HIV PrEP Medications with Hormonal Contraception
- Baseline Laboratory Evaluation for Women Starting HIV PrEP
- Time for Women to Achieve Protection After Initiating HIV PrEP
- Follow-Up and Laboratory Monitoring for Women Receiving HIV PrEP
- Summary Points
3Lesson 3 HIV PrEP for People Who Inject Drugs
- Learning Objectives
- Explain the risk factors and impact of the opioid epidemic that contribute to HIV acquisition among people who inject drugs (PWID) in the United States
- Summarize the HIV epidemiology, clinical trial evidence, and indications that support the use of HIV PrEP in PWID
- Discuss the clinical management of HIV PrEP for PWID including substance use screening, sexual history, baseline evaluation, PrEP medications, follow-up monitoring, and adherence
- Describe the barriers to HIV PrEP uptake in PWID and the strategies to increase HIV PrEP uptake in PWID
- Provide a rationale for additional services for PWID that address opioid use and mental health disorders, and prevent other viral and bacterial infectious diseases
- Quick ReferenceHIV PrEP for People Who Inject Drugs Core Concepts
- Background
- Epidemiology of HIV among PWID
- Factors Associated with Increased Risk for HIV Among PWID
- Evidence for HIV PrEP Among PWID
- Assessing Indications for HIV PrEP Among PWID
- Recommended HIV PrEP Medications for PWID
- Baseline Laboratory Evaluation
- Time to Achieve Protection
- Follow-Up and Laboratory Monitoring
- Implementation of HIV PrEP for PWID
- Additional Care Services for PWID
- Summary Points
4Lesson 4 Same Day (Rapid) Start for Oral HIV PrEP
- Learning Objectives
- Discuss the rationale for delivering same-day (rapid) start of oral HIV PrEP
- Define the concepts and terms specific to same-day (rapid) and standard HIV PrEP
- Summarize the descriptive studies on implementation and outcomes of same-day (rapid) oral HIV PrEP
- Differentiate clinic settings best suited to provide same-day (rapid) oral HIV PrEP services
- List the laboratory tests required prior to and the day of prescribing oral HIV PrEP
- Quick ReferenceSame Day (Rapid) Start for Oral HIV PrEP Core Concepts
5Lesson 5 Providing HIV PrEP in Sexual Health Clinic Settings
- Learning Objectives
- Discuss the rationale for providing HIV PrEP services in sexual health clinics based on epidemiology, population served, and sexual health clinic attributes
- Summarize the evidence for the successful integration of HIV PrEP in sexual health clinics, as well as logistical and financial considerations
- Identify HIV PrEP eligibility criteria, screening tools, and partner notification services
- Explain how to optimize HIV PrEP uptake and use via education, outreach, staffing, follow-up, ongoing care, program monitoring
- Describe cost-saving programs for HIV PrEP integration, including 340B eligibility
- Quick ReferenceProviding HIV PrEP in Sexual Health Clinic Settings Core Concepts
- Background
- Rationale for Providing HIV PrEP in Sexual Health Clinics
- Evidence for Providing HIV PrEP in Sexual Health Clinics
- Identifying HIV PrEP Candidates in Sexual Health Clinics
- Identifying and Addressing Barriers in Sexual Health Clinics
- Optimizing Implementation of HIV PrEP in Sexual Health Clinics
- HIV PrEP Follow-Up and Ongoing Care
- Establish and Analyze Clinic HIV PrEP Metrics
- Financial Considerations for PrEP Integration into SHC
- Summary Points
Share by e-mail
Check
-On-
Learning
QuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.You must be signed in to customize your interaction with these questions.
- 0%Lesson 2
The National HIV PrEP Curriculum is supported by the Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as a part of a financial assistance award totaling $300,000 from CDC and $299,990 from HRSA with 0% financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by CDC, HRSA, or HHS, or the U.S. Government. This project is led by the University of Washington Infectious Diseases Education & Assessment (IDEA) Program.
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: prepc-monorepo-7785ca90-2025-07-04-010017
Become a New User
Account Registration Benefits:
- Track your progress on the lessons
- Earn free CNE/CME/CE
- Earn Certificates of Completion
- Access to other free IDEA curricula
Create a free account to get started